Advertisement

Topics

Genomic Health, Inc. Company Profile

19:26 EST 23rd November 2017 | BioPortfolio

Genomic Health, Inc. (NASDAQ: GHDX) is a life science company focused on the global development and commercialization of genomic-based clinical laboratory services for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched the Oncotype DX® breast cancer test, which has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in early-stage breast cancer. In addition to the widely adopted Oncotype DX breast cancer test, Genomic Health launched its Oncotype DX colon cancer test in January 2010. As of March 31, 2010, more than 10,000 physicians in over 55 countries had ordered more than 148,000 Oncotype DX tests. The company was founded in 2000 and is located in Redwood City, California. For more information, please visit www.genomichealth.com.


News Articles [574 Associated News Articles listed on BioPortfolio]

Genomic Health develops Oncotype DX test for breast cancer on Biocartis' Idylla system

Biocartis Group NV and Genomic Health Inc. agreed to work together to develop an in vitro diagnostic version of Genomic Health’s Oncotype DX Breast Recurrence Score test that will run on Biocartis...

Genomic Health enters exclusive co-development deal with Biocartis

An in vitro diagnostic version of Genomic Health's Oncotype DX Breast Recurrence Score test that will run on Biocartis' Idyll -More- 

Genomic Health Continues To Pioneer Genomic-Based Cancer Diagnostics With Multiple Presentations At 2017 Congress

  Life Sciences Jobs   ...

GA4GH strikes formal collaborations with 15 international genomic data initiatives

(Global Alliance for Genomics and Health) GA4GH has struck formal collaborations with 15 international genomic data initiatives as 2017 Driver Projects as part of GA4GH Connect, a new phase of the org...

Genomic Health Release: Updated St. Gallen International Breast Cancer Guidelines Reinforce Important Role Of Genomic Testing In Treatment Of Early Breast Cancer

  Life Sciences Jobs   ...

IBM Watson impresses in brain tumour analysis

IBM is busy applying its Watson AI to as many health arenas as possible and it looks like cancer genomic sequencing could be its next big market.   In a new proof-of-concept study testing a beta ve...

Genomic Health Continues to Pioneer Genomic-based Cancer Diagnostics with Multiple ...

A first-of-its-kind analysis from the National Cancer Institute's population-based SEER Registry evaluating breast cancer-specific survival in young women under 40 years old; First time present...

Updated Breast Cancer Guidelines Reinforce Important Role of Genomic Testing in Treatment of Early Breast Cancer

NewsGene expression signatures recommended for the first time as preferable to standard pathology when adequate reproducibility is not granted.

PubMed Articles [4333 Associated PubMed Articles listed on BioPortfolio]

Exploring the feasibility of delivering standardized genomic care using ophthalmology as an example.

Broadening access to genomic testing and counseling will be necessary to realize the benefits of personalized health care. This study aimed to assess the feasibility of delivering a standardized genom...

Swine models, genomic tools and services to enhance our understanding of human health and diseases.

The pig is becoming increasingly important as a biomedical model. Given the similarities between pigs and humans, a greater understanding of the underlying biology of human health and diseases may com...

Genomic Approaches to Hypertension.

Genomic insights and analyses of Mendelian hypertension (HTN) syndromes and Genome-Wide Association study (GWAS) on essential hypertension have contributed to the depth of understanding of the genetic...

Participatory Genomic Research: Ethical Issues from the Bottom Up to the Top Down.

Participatory approaches to genomic research manifest along a continuum from bottom-up citizen-science initiatives designed to liberate scientific inquiry from the constraints of traditional research ...

Empowering Mayo Clinic Individualized Medicine with Genomic Data Warehousing.

Individualized medicine enables better diagnoses and treatment decisions for patients and promotes research in understanding the molecular underpinnings of disease. Linking individual patient's genomi...

Clinical Trials [2715 Associated Clinical Trials listed on BioPortfolio]

Rady Children's Institute Genomic Biorepository

Rady Children's Institute for Genomic Medicine (RCI) will collect biological samples (such as blood), derived genomic sequences (from DNA and RNA), and clinical features in a Biorepository...

Pan-genome Analysis of Neuroblastoma by Comparative Genomic Hybridization and Correlation With Pathology for the Diagnostic and the Prognostic Classification

Neuroblastoma (NB) is characterized by its wide heterogeneity in clinical presentation and evolution. Recent retrospective studies have revealed by CGH-array that the overall genomic patte...

Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer

This research trial studies the use of targeted genomic analysis of blood and tissue samples from patients with cancer. Genomic sequencing is a laboratory method that is used to determine ...

Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer

Overall survival rates for patients with metastatic NSCLC are poor utilizing conventional cytotoxic chemotherapy approaches. However, a subset of patients harbor genomic driver mutations, ...

Advanced Cancer Patients Decision Making and Family Communication About Secondary Findings From Tumor Genomic Profiling

The objective of this protocol is to characterize advanced cancer patients' responses to learning their secondary findings arising from tumor genomic profiling, and the process and outcome...

Companies [1961 Associated Companies listed on BioPortfolio]

Genomic Health

Genomic Health gives cancer patients and physicians insight needed to help make quality treatment decisions. GenomicHealth.com is designed to help patients, caregivers and healthcare professionals und...

Genomic Health, Inc.

Genomic Health, Inc. (NASDAQ: GHDX) is a life science company focused on the global development and commercialization of genomic-based clinical laboratory services for cancer that allow physicians and...

Bina Technologies, Inc.

Bina Technologies builds next-generation technologies for scalable, accurate processing and management of genomic information. Bina’s Genomic Management Solution is a compreh...

DxTerity Diagnostics Inc.

DxTerity is a molecular diagnostic company and clinical laboratory based in Rancho Dominguez, CA, that is making genomic testing a routine part of medical care. DxTerity has devel...

Genomic Expression, Inc.

Genomic Expression’s mission is to save lives and to make the delivery of healthcare more effective. The inconvenient truth is that only one out of four cancer treatments pro...

More Information about "Genomic Health, Inc." on BioPortfolio

We have published hundreds of Genomic Health, Inc. news stories on BioPortfolio along with dozens of Genomic Health, Inc. Clinical Trials and PubMed Articles about Genomic Health, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Genomic Health, Inc. Companies in our database. You can also find out about relevant Genomic Health, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record